Amlexanox inhibition of TBK1/IKK epsilon Signaling Is a Novel Therapeutic Approach for Multiple Myeloma-Induced Bone Disease / Sun, Qh; Zhang, P; Adamik, J; Marchica, V; Giuliani, N; Silbermann, R; Roodman, Gd; Galson, Dl. - In: JOURNAL OF BONE AND MINERAL RESEARCH. - ISSN 0884-0431. - 32(2017), pp. S313-S313.
Titolo: | Amlexanox inhibition of TBK1/IKK epsilon Signaling Is a Novel Therapeutic Approach for Multiple Myeloma-Induced Bone Disease. | |
Autori: | ||
Data di pubblicazione: | 2017 | |
Rivista: | ||
Citazione: | Amlexanox inhibition of TBK1/IKK epsilon Signaling Is a Novel Therapeutic Approach for Multiple Myeloma-Induced Bone Disease / Sun, Qh; Zhang, P; Adamik, J; Marchica, V; Giuliani, N; Silbermann, R; Roodman, Gd; Galson, Dl. - In: JOURNAL OF BONE AND MINERAL RESEARCH. - ISSN 0884-0431. - 32(2017), pp. S313-S313. | |
Handle: | http://hdl.handle.net/11381/2837671 | |
Appare nelle tipologie: | 1.5 Abstract in Rivista |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.